Weight-Loss Drug Wegovy Could Reduce Risk of Heart Attack, Stroke By LAURYN HIGGINS Wegovy is linked to a reduced risk of heart attack, stroke, and heart-related death, according to the results of a new clinical trial.2The findings from Novo Nordisk are the first to show that a diabetes drug commonly used off-label for weight loss…
This content is for 3 Months, 6 Months, and 12 Months members only.
Join Now
Join Now
Already a member? Log in here
